CoapTech News

• The spring conference season dovetailed into increased clinical interest over the summer. Several interested doctors followed up with us directly to pursue clinical research opportunities. Stay tuned for more updates on this - and of course, if you're interested in research at your institution, see our early adopter page.

• Summer also yielded CoapTech's first commercial-level manufacturing effort. We are excited to share some pictures below. Subsequent lots are in the works. 
  
  
• Final product testing is underway for FDA (and CE Mark) technical files. Preliminary test results have been promising - including our GLP canine study in June.
  
  
• The company just won an award for "Medical Device Incubator Company of the Year" for Maryland Incubators! A big Thank You to everyone who helped us along the way. 

CoapTech Granted European Patent for PUMA Technology

A gastrostomy can be a life-saving medical procedure for critically ill patients, providing much-needed nutrition, but this popular procedure also involves inherent risks.

CoapTech seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patent-pending, disruptive technology called Coaptive Ultrasound which is owned by the company.  CoapTech devices will reduce health care costs, and improve safety, quality, patient experience, and access to services around the globe.     

- Start-up Company Developing Safer, Less Expensive Gastrostomy Method